XML 96 R81.htm IDEA: XBRL DOCUMENT v3.25.3
Segment Disclosures - Schedule of Information for the Reportable Segments (Details) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2025
Sep. 30, 2024
Mar. 31, 2024
Sep. 30, 2025
Sep. 30, 2024
Segment Reporting Information, Revenue for Reportable Segment [Abstract]          
Total revenues $ 705,873 $ 700,397   $ 2,103,110 $ 2,002,461
Plus: Adjustments to NOI 25,878 27,825   76,941 80,842
Interest income and other 15,529 14,301   47,156 27,884
Interest expense (76,784) (74,105)   (224,540) (209,922)
Depreciation and amortization (262,317) (280,019)   (796,779) (782,736)
General and administrative (19,907) (23,216)   (66,789) (73,233)
Transaction and merger-related costs (2,420) (7,134)   (18,169) (122,113)
Impairments and loan loss reserves, net 54 (441)   117 (11,346)
Gain (loss) on sales of real estate, net 11,500 62,325   13,136 187,624
Other income (expense), net 1,160 982   (9,658) 83,502
Less: Healthpeak’s share of unconsolidated joint venture Adjusted NOI (9,045) (7,664)   (24,392) (20,068)
Plus: Noncontrolling interests’ share of consolidated joint venture Adjusted NOI 6,569 6,883   20,983 20,207
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures 65,237 98,510   159,182 276,402
Outpatient Medical          
Segment Reporting Information, Revenue for Reportable Segment [Abstract]          
Gain (loss) on sales of real estate, net 12,000 60,000 $ 3,000    
Operating Segment          
Segment Reporting Information, Revenue for Reportable Segment [Abstract]          
Total revenues 690,344 686,096   2,055,954 1,974,577
Healthpeak’s share of unconsolidated joint venture total revenues 14,161 12,307   38,761 31,111
Noncontrolling interests’ share of consolidated joint venture total revenues (10,334) (9,734)   (30,327) (28,148)
Operating expenses (291,922) (280,279)   (841,246) (797,835)
Healthpeak’s share of unconsolidated joint venture operating expenses (5,116) (4,643)   (14,369) (11,043)
Noncontrolling interests’ share of consolidated joint venture operating expenses 3,765 2,851   9,344 7,941
Adjustments to NOI (25,878) (27,825)   (76,941) (80,842)
Adjusted NOI for reportable segments 375,020 378,773   1,141,176 1,095,761
Income (loss) before income taxes and equity income (loss) from unconsolidated joint ventures 65,237 98,510   159,182 276,402
Operating Segment | Outpatient Medical          
Segment Reporting Information, Revenue for Reportable Segment [Abstract]          
Total revenues 326,561 317,659   967,591 888,446
Healthpeak’s share of unconsolidated joint venture total revenues 7,327 7,065   21,769 16,707
Noncontrolling interests’ share of consolidated joint venture total revenues (10,334) (9,734)   (30,327) (27,952)
Operating expenses (113,660) (106,484)   (324,216) (299,455)
Healthpeak’s share of unconsolidated joint venture operating expenses (2,887) (2,832)   (8,576) (6,380)
Noncontrolling interests’ share of consolidated joint venture operating expenses 3,765 2,851   9,344 7,889
Adjustments to NOI (10,358) (11,020)   (33,253) (27,573)
Adjusted NOI for reportable segments 200,414 197,505   602,332 551,682
Operating Segment | Lab          
Segment Reporting Information, Revenue for Reportable Segment [Abstract]          
Total revenues 213,325 225,592   640,123 663,619
Healthpeak’s share of unconsolidated joint venture total revenues 6,834 5,242   16,992 14,404
Noncontrolling interests’ share of consolidated joint venture total revenues 0 0   0 (196)
Operating expenses (64,352) (64,075)   (181,412) (177,571)
Healthpeak’s share of unconsolidated joint venture operating expenses (2,229) (1,811)   (5,793) (4,663)
Noncontrolling interests’ share of consolidated joint venture operating expenses 0 0   0 52
Adjustments to NOI (15,520) (16,900)   (42,844) (51,624)
Adjusted NOI for reportable segments 138,058 148,048   427,066 444,021
Operating Segment | CCRC          
Segment Reporting Information, Revenue for Reportable Segment [Abstract]          
Total revenues 150,458 142,845   448,240 422,512
Healthpeak’s share of unconsolidated joint venture total revenues 0 0   0 0
Noncontrolling interests’ share of consolidated joint venture total revenues 0 0   0 0
Operating expenses (113,910) (109,720)   (335,618) (320,809)
Healthpeak’s share of unconsolidated joint venture operating expenses 0 0   0 0
Noncontrolling interests’ share of consolidated joint venture operating expenses 0 0   0 0
Adjustments to NOI 0 95   (844) (1,645)
Adjusted NOI for reportable segments $ 36,548 $ 33,220   $ 111,778 $ 100,058